TrialJournal of neurology, neurosurgery, and psychiatry2016

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.

Jeffrey A Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.